Skip to main content
Wearable and Cuffless Technologies
  1. Home
  2. Blood Pressure Technology
  3. Wearable and Cuffless Technologies
BIHS Wearables and Cuffles Devices Programme: Evaluation, Data Integration and NHS Implementation

BIHS is convening a UK-wide programme to support the safe, effective and scalable integration of wearable blood pressure technologies into NHS care.

Wearable blood pressure technologies present a significant opportunity, but their route into clinical use must be practical, proportionate and evidence-led. International standards remain an important global reference for technical validation. BIHS’s focus is on the next question: how evidence should translate into safe, usable and scalable adoption within UK clinical pathways.

This programme brings together experts from academia, the NHS, industry and digital health to define a coordinated UK approach. It is designed to support three linked objectives:

  • a proportionate evaluation framework for defined use cases
  • a clinically useful data and workflow model for NHS implementation
  • a phased route from early evidence generation to real-world service evaluation
This is a living roadmap.

BIHS is publishing discussion documents, draft position notes and practical workstream outputs to help align activity across the UK. We encourage researchers, NHS teams, innovators and funding partners to reference this roadmap in proposals, pilots and implementation planning.

 

Current

Programme

Position

Learn more

 

 

Related Activity  

Learn more

 

 

Important clarification

BIHS is not currently approving any wearable or cuffless blood pressure devices for routine clinical use.

A device may hold regulatory clearance or CE marking for a particular purpose, and may also have published validation or performance data. These are important but distinct issues. BIHS’s programme is focused on how such technologies should be evaluated, interpreted and introduced within UK clinical pathways, including the evidence, governance and implementation conditions needed for safe use.

In practical terms, BIHS distinguishes between:

  • regulatory status
  • technical validation or performance evidence
  • controlled evaluation in defined NHS-relevant use cases
  • support for broader clinical adoption
BIHS supports a proportionate, evidence-led route to the evaluation and adoption of wearable and cuffless blood pressure technologies in the UK. Regulatory status, technical validation, controlled evaluation and clinical endorsement are not the same thing. Our programme is intended to clarify that route, support safe NHS implementation, and help align research, service development and funding activity.